Munich - Delayed Quote • EUR
Sinopharm Group Co Ltd (X2S.MU)
As of 8:11 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
591,685,675.6070
552,147,550.0000
521,051,235.0000
456,414,611.0000
Cost of Revenue
--
504,713,490.0000
477,000,627.0000
416,091,300.0000
Gross Profit
--
47,434,060.0000
44,050,608.0000
40,323,311.0000
Operating Expense
63,770,262.6820
24,226,957.0000
22,609,333.0000
20,539,551.0000
Operating Income
23,201,922.9250
23,207,103.0000
21,441,275.0000
19,783,760.0000
Net Non Operating Interest Income Expense
-2,964,647.2134
-3,189,992.0000
-3,402,869.0000
-2,944,189.0000
Pretax Income
19,000,578.9906
18,563,819.0000
17,003,162.0000
15,598,096.0000
Tax Provision
4,400,314.2593
4,218,377.0000
3,938,389.0000
3,500,805.0000
Net Income Common Stockholders
8,765,042.4722
8,525,655.0000
7,758,646.0000
7,187,204.0000
Diluted NI Available to Com Stockholders
8,765,042.4722
8,525,655.0000
7,758,646.0000
7,187,204.0000
Basic EPS
2.81
2.73
2.49
2.31
Diluted EPS
2.81
2.73
2.49
2.31
Basic Average Shares
3,116,889.7680
3,120,656.0000
3,111,169.0000
3,111,169.0000
Diluted Average Shares
3,116,889.7680
3,120,656.0000
3,111,169.0000
3,111,293.0000
Total Operating Income as Reported
21,061,434.4390
20,604,466.0000
19,711,976.0000
17,759,975.0000
Total Expenses
568,483,752.6820
528,940,447.0000
499,609,960.0000
436,630,851.0000
Net Income from Continuing & Discontinued Operation
8,765,042.4722
8,525,655.0000
7,758,646.0000
7,187,278.0000
Normalized Income
10,727,800.3603
10,504,074.7776
9,431,717.8980
8,960,015.7304
Interest Income
--
542,767.0000
558,562.0000
676,358.0000
Interest Expense
3,294,981.2134
3,520,326.0000
3,756,835.0000
3,424,756.0000
Net Interest Income
-2,964,647.2134
-3,189,992.0000
-3,402,869.0000
-2,944,189.0000
EBIT
22,295,560.2039
22,084,145.0000
20,759,997.0000
19,022,852.0000
EBITDA
22,295,560.2039
26,249,164.0000
24,682,055.0000
22,619,966.0000
Reconciled Cost of Revenue
--
504,713,490.0000
477,000,627.0000
416,091,300.0000
Reconciled Depreciation
3,373,216.0000
4,165,019.0000
3,922,058.0000
3,597,114.0000
Net Income from Continuing Operation Net Minority Interest
8,765,042.4722
8,525,655.0000
7,758,646.0000
7,187,278.0000
Total Unusual Items Excluding Goodwill
-2,554,305.4855
-2,560,067.0000
-2,177,345.0000
-2,285,634.0000
Total Unusual Items
-2,554,305.4855
-2,560,067.0000
-2,177,345.0000
-2,285,634.0000
Normalized EBITDA
24,849,865.6894
28,809,231.0000
26,859,400.0000
24,905,600.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
-591,547.5974
-581,647.2224
-504,273.1020
-512,896.2696
12/31/2020 - 9/23/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade